Results 281 to 290 of about 111,871 (303)
Some of the next articles are maybe not open access.
PARP inhibitors: pitfalls and promises
The Lancet Oncology, 2013Jeffrey R, Infante, Howard A, Burris
openaire +2 more sources
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer
Nature Reviews Clinical Oncology, 2016Angela George, Susana Banerjee
exaly
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
Nature Reviews Clinical Oncology, 2013Joaquin Mateo +2 more
exaly

